Excision BioTherapeutics (@excisionbio) 's Twitter Profile
Excision BioTherapeutics

@excisionbio

Developing CRISPR-based therapies intended to cure viral infectious diseases.

ID: 3739646957

linkhttps://www.excision.bio calendar_today22-09-2015 14:32:02

214 Tweet

1,1K Followers

266 Following

Excision BioTherapeutics (@excisionbio) 's Twitter Profile Photo
Excision BioTherapeutics
@excisionbio

3 years ago

Today Excision announced the dosing of our first participant in EBT-101 Phase 1/2 trial evaluating EBT-101 as a potential cure for HIV. Read our press release: bit.ly/3xlVIJV

Today Excision announced the dosing of our first participant in EBT-101 Phase 1/2 trial evaluating EBT-101 as a potential cure for HIV. Read our press release: bit.ly/3xlVIJV